$1m/month revenue, excess inst' demand + + +, page-3

JP, as shareholders he is already.
Reiner001, Working on that ....

Good luck to all holders.
And if you haven't bought yet, don't have a "doh", "missed that one" moment, lol.

It's been a while between drinks. I am feeling pretty good about STI (pharma) with this news, CCC with the news due this morning before open (coal) and MXR (with high grade gold) and quarterly out after the close yesterday ( wed). All three in my stock picks, my portfolio's and been posting about for what seems like forever. Some of my others still asleep but with the reporting over the next two days, will hopefully have some price sensitive good news for the market.

I don't think it's too long before STI has a BIG volume and price day. With the earnings now underway and potential for exponential growth, it's just one of those market wonders as to why the market cap is $11m and not 5 plus times that. A Price to Earnings Ratio of 20 for an emerging revenue/ growth company is conservative.